Soligenix Inc.
SNGX
$0.35+2.21%
Delayed · as of Oct 15, 2026, 2:01 PM ET
Mkt cap
$5.96M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2024-09-30)
$119,371
EPS (H1 2026)
$-0.37
Gross Margin (qtr ended 2024-09-30)
N/A
Profit Margin (qtr ended 2024-09-30)
-1440.37%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Soligenix Inc. (SNGX) is a biotechnology company listed on NASDAQ.
Latest reported SNGX revenue for 2024-09-30 was $119.4K. Net income was -$1.7M. SNGX currently screens at market cap $6.0M.
Use this SNGX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SNGX income, balance, and cash tables.
Soligenix Inc. (SNGX) is a biotechnology company in the Healthcare sector.
Latest cached Soligenix Inc. (SNGX) revenue for Sep 30, 2024 was $119.4K. Net income was -$1.7M. Statements: https://lician.com/financials/sngx
Soligenix Inc. (SNGX) market capitalization is $6.0M on the latest cached snapshot.
Soligenix Inc. (SNGX) cached previous close $0.34; day range $0.34 – $0.35; volume 88,008. Session quote: https://lician.com/quote/sngx
Soligenix Inc. (SNGX) latest cached earnings event is "SNGX earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SNGX filing is 8-K · Sep 21, 2026. Filings: https://lician.com/sec/sngx